{
  "test_metadata": {
    "timestamp": "2025-12-11T18:32:02.893355",
    "test_type": "complete_pipeline_validation",
    "improvements_version": "phase_1_to_4_complete"
  },
  "payload": {
    "client_id": "lai_weekly_v2_test",
    "period_days": 7,
    "from_date": "2024-12-04",
    "to_date": "2024-12-10",
    "target_date": "2024-12-11",
    "test_items": [
      {
        "id": "test_nanexa_moderna_pharmashell",
        "title": "Nanexa and Moderna Announce Partnership for PharmaShell® Technology",
        "content": "Nanexa AB announced a strategic partnership with Moderna to develop long-acting injectable formulations using PharmaShell® technology for extended-release applications.",
        "date": "2024-12-10",
        "source_type": "press_corporate",
        "companies_detected": [
          "Nanexa",
          "Moderna"
        ],
        "technologies_detected": [
          "PharmaShell®",
          "long-acting injectable",
          "extended-release"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "partnership",
        "lai_relevance_score": 9,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "high"
        },
        "score": 9.0
      },
      {
        "id": "test_uzedy_regulatory",
        "title": "UZEDY Receives FDA Approval for Extended Treatment",
        "content": "The FDA has approved UZEDY for extended treatment protocols, marking a significant regulatory milestone for long-acting injectable antipsychotics.",
        "date": "2024-12-09",
        "source_type": "press_sector",
        "companies_detected": [
          "MedinCell"
        ],
        "technologies_detected": [
          "long-acting injectable"
        ],
        "molecules_detected": [],
        "trademarks_detected": [
          "UZEDY"
        ],
        "event_type": "regulatory",
        "lai_relevance_score": 10,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "high"
        },
        "score": 21.0
      },
      {
        "id": "test_medincel_malaria_grant",
        "title": "MedinCell Receives Grant for Malaria Prevention Program",
        "content": "MedinCell has been awarded a significant grant to develop long-acting injectable solutions for malaria prevention in endemic regions.",
        "date": "2024-12-08",
        "source_type": "press_corporate",
        "companies_detected": [
          "MedinCell"
        ],
        "technologies_detected": [
          "long-acting injectable"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "clinical_update",
        "lai_relevance_score": 8,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "medium"
        },
        "score": 8.0
      },
      {
        "id": "test_delsitech_hr",
        "title": "DelSiTech is Hiring Process Engineers",
        "content": "DelSiTech seeks experienced process engineers to join our manufacturing team. We are recruiting for multiple positions in our drug delivery systems division.",
        "date": "2024-12-07",
        "source_type": "press_corporate",
        "companies_detected": [
          "DelSiTech"
        ],
        "technologies_detected": [],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "corporate_move",
        "lai_relevance_score": 3,
        "anti_lai_detected": false,
        "pure_player_context": false
      },
      {
        "id": "test_medincel_finance",
        "title": "MedinCell Publishes Quarterly Financial Results",
        "content": "MedinCell publishes its interim report showing strong financial results for the quarter with improved revenue guidance.",
        "date": "2024-12-06",
        "source_type": "press_corporate",
        "companies_detected": [
          "MedinCell"
        ],
        "technologies_detected": [],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "financial_results",
        "lai_relevance_score": 2,
        "anti_lai_detected": false,
        "pure_player_context": false
      },
      {
        "id": "test_pfizer_oral_glp1",
        "title": "Pfizer Advances Oral GLP-1 Tablet Development",
        "content": "Pfizer announces progress in developing oral tablet formulations for GLP-1 medications, focusing on oral drug delivery systems.",
        "date": "2024-12-05",
        "source_type": "press_sector",
        "companies_detected": [
          "Pfizer"
        ],
        "technologies_detected": [
          "oral tablet",
          "oral drug"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "clinical_update",
        "lai_relevance_score": 4,
        "anti_lai_detected": true,
        "pure_player_context": false
      },
      {
        "id": "test_siliaShell_technology",
        "title": "Breakthrough in SiliaShell® Technology for Drug Delivery",
        "content": "New developments in SiliaShell® technology show promising results for controlled-release applications in pharmaceutical manufacturing.",
        "date": "2024-12-04",
        "source_type": "press_sector",
        "companies_detected": [
          "TechPharma"
        ],
        "technologies_detected": [
          "SiliaShell®",
          "controlled-release"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "scientific_publication",
        "lai_relevance_score": 7,
        "anti_lai_detected": false,
        "pure_player_context": false,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "medium"
        },
        "score": 4.5
      }
    ]
  },
  "pipeline_results": {
    "matched_items_count": 4,
    "scored_items_count": 4,
    "selected_items_count": 3
  },
  "newsletter": {
    "metadata": {
      "generated_at": "2025-12-11T18:32:02.892595",
      "client_id": "lai_weekly_v2_test",
      "period": "2024-12-04 to 2024-12-10",
      "total_items_processed": 4,
      "items_selected": 3,
      "selection_rate": 75.0
    },
    "sections": {
      "high_priority": [
        "test_uzedy_regulatory"
      ],
      "medium_priority": [],
      "low_priority": [
        "test_nanexa_moderna_pharmashell",
        "test_medincel_malaria_grant"
      ]
    },
    "items_details": [
      {
        "id": "test_uzedy_regulatory",
        "title": "UZEDY Receives FDA Approval for Extended Treatment",
        "content": "The FDA has approved UZEDY for extended treatment protocols, marking a significant regulatory milestone for long-acting injectable antipsychotics.",
        "date": "2024-12-09",
        "source_type": "press_sector",
        "companies_detected": [
          "MedinCell"
        ],
        "technologies_detected": [
          "long-acting injectable"
        ],
        "molecules_detected": [],
        "trademarks_detected": [
          "UZEDY"
        ],
        "event_type": "regulatory",
        "lai_relevance_score": 10,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "high"
        },
        "score": 21.0
      },
      {
        "id": "test_nanexa_moderna_pharmashell",
        "title": "Nanexa and Moderna Announce Partnership for PharmaShell® Technology",
        "content": "Nanexa AB announced a strategic partnership with Moderna to develop long-acting injectable formulations using PharmaShell® technology for extended-release applications.",
        "date": "2024-12-10",
        "source_type": "press_corporate",
        "companies_detected": [
          "Nanexa",
          "Moderna"
        ],
        "technologies_detected": [
          "PharmaShell®",
          "long-acting injectable",
          "extended-release"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "partnership",
        "lai_relevance_score": 9,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "high"
        },
        "score": 9.0
      },
      {
        "id": "test_medincel_malaria_grant",
        "title": "MedinCell Receives Grant for Malaria Prevention Program",
        "content": "MedinCell has been awarded a significant grant to develop long-acting injectable solutions for malaria prevention in endemic regions.",
        "date": "2024-12-08",
        "source_type": "press_corporate",
        "companies_detected": [
          "MedinCell"
        ],
        "technologies_detected": [
          "long-acting injectable"
        ],
        "molecules_detected": [],
        "trademarks_detected": [],
        "event_type": "clinical_update",
        "lai_relevance_score": 8,
        "anti_lai_detected": false,
        "pure_player_context": true,
        "matched_domains": [
          "tech_lai_ecosystem"
        ],
        "matching_details": {
          "domain_id": "tech_lai_ecosystem",
          "rule_applied": "contextual_matching",
          "match_confidence": "medium"
        },
        "score": 8.0
      }
    ]
  },
  "comparison_with_baseline": {
    "expected_behavior": {
      "should_include": [
        "test_nanexa_moderna_pharmashell",
        "test_uzedy_regulatory",
        "test_medincel_malaria_grant",
        "test_siliaShell_technology"
      ],
      "should_exclude": [
        "test_delsitech_hr",
        "test_medincel_finance",
        "test_pfizer_oral_glp1"
      ]
    },
    "actual_results": {
      "correctly_included": [
        "test_nanexa_moderna_pharmashell",
        "test_uzedy_regulatory",
        "test_medincel_malaria_grant"
      ],
      "missed_inclusions": [
        "test_siliaShell_technology"
      ],
      "correctly_excluded": [
        "test_delsitech_hr",
        "test_medincel_finance",
        "test_pfizer_oral_glp1"
      ],
      "incorrect_inclusions": []
    },
    "metrics": {
      "inclusion_accuracy": 0.75,
      "exclusion_accuracy": 1.0,
      "overall_accuracy": 0.8571428571428571
    },
    "success_criteria_met": {
      "nanexa_moderna_included": true,
      "uzedy_included": true,
      "medincel_malaria_included": true,
      "hr_noise_excluded": true,
      "finance_noise_excluded": true,
      "oral_route_excluded": true
    },
    "overall_success_rate": 1.0
  },
  "deployment_recommendation": {
    "recommendation": "DEPLOY_TO_AWS",
    "confidence": "HIGH",
    "reason": "Taux de réussite excellent (100.0%). Tous les critères critiques sont satisfaits.",
    "next_steps": [
      "Déployer les configurations sur AWS",
      "Exécuter un run de production",
      "Monitorer les premières newsletters générées",
      "Comparer avec les newsletters précédentes"
    ]
  }
}